Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis



Rating:

Share or cite this content

Citations should be made in the following way:
B. Haecker (Berlin, Germany), T. Schaberg (Berlin, Germany), R. Otto-Knapp (Berlin, Germany), A. Nienhaus (Hamburg, Germany), C. Kneitz (Schwerin, Germany), M. Fabri (Cologne, Germany), A. Krause (Berlin, Germany), U. Mrowietz (Kiel, Germany), T. Bauer (Berlin, Germany), R. Diel (Großhansdorf, Germany). Risk of Tuberculosis reactivation during treatment with non TNFi/Biologics. 1039

Member's Comments

No comment yet.

Related content which might interest you: Risk of developing active TB in children with latent TB infection Source: International Congress 2015 – Screening strategies in TB Year: 2015 Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Risk factors for disseminated tuberculosis Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Impact of drug injection using on TB-AIDS treatment outcomes Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Risk factors for acquired drug-resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity Source: International Congress 2015 – Screening strategies in TB Year: 2015 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Predictive factors of a delayed culture conversion under tuberculosis treatment Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Risk factors of hepatotoxicity during tuberculosis treatment and management Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Risk factors of severe clinical forms of tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Tuberculosis recurrence Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Predictive factors of recurrent pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Outcomes of directly observed treatment for drug resistant tuberculosis Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Risk factors for anti-TB drug resistance in Poland Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013